Sanofi
時価総額
$100.5B
世界順位
#164
過去最高値
$109.9B
2024-12-31
総成長率
+0%
2026年以降
Market Cap Context
- Larger than 55% of the 367 companies we track (globally).
- Equivalent to 3.0% of France's GDP (2025 data).
- Just above: #163 AXA SA ($100.6B)
- Just below: #165 タタ・コンサルタンシー・サービシズ（TCS） ($99.0B)
- Best year: 2012 (+32%). Worst year: 2002 (-30%).
Sanofi Financial Breakdown (FY 2025)
Source: Yahoo Finance — SAN.PA annual filings (2025) (converted from EUR at 0.93) →$50.2B revenue · $10.3B operating income · $8.4B net income
- ●Operating margin: 20.5% on $50.2B in revenue.
- ●R&D is 16.8% of revenue ($8.4B).
- ●Net income margin: 16.7% — $8.4B in profit.
- ●Free cash flow: $7.8B (15.4% of revenue).
Cost / Operating Expenses
Total operating expenses $39.9B
Total
$33.5B
Capital Expenditures
$3.8B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$7.8B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
Sanofiについて
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo. In 2004, Sanofi-Synthélabo merged with Aventis and renamed to Sanofi-Aventis, which were each the product of several previous mergers. It changed its name back to Sanofi in May 2011. The company trades as "SAN" on Euronext Paris and "SNY" on Nasdaq in the United States, and is a component of the Euro Stoxx 50 stock market index. In 2023, the company was ranked 89th in the Forbes Global 2000.
Sanofiの時価総額推移 (2026–2026)
Sanofi vs Sector Peers by Market Cap
Sanofiを比較
順位の推移
| 年 | 時価総額 | 順位 | 前年比 |
|---|---|---|---|
| 2026 | $100.5B | #164(↓16) | -0.8% |
| 2025 | $101.3B | #148(↓25) | -7.9% |
| 2024 | $109.9B | #123(↓12) | +8.8% |
| 2023 | $101.1B | #111(↓14) | +3.6% |
| 2022 | $97.5B | #97(↑12) | +5.5% |
| 2021 | $92.4B | #109(↓1) | +16.9% |
| 2020 | $79.1B | #108(↓30) | -9.0% |
| 2019 | $86.8B | #78(↓8) | +23.4% |
| 2018 | $70.3B | #70(↑16) | +10.4% |
| 2017 | $63.7B | #86(↓29) | -3.5% |
| 2016 | $66.0B | #57(↓1) | +2.0% |
| 2015 | $64.7B | #56(↑3) | +7.2% |
| 2014 | $60.3B | #59(↓6) | +1.8% |
| 2013 | $59.3B | #53(↓12) | +11.6% |
| 2012 | $53.1B | #41(↑8) | +31.8% |
| 2011 | $40.3B | #49(↑16) | +24.1% |
| 2010 | $32.5B | #65(↓14) | -8.7% |
| 2009 | $35.6B | #51(↓5) | +27.9% |
| 2008 | $27.8B | #46(↑10) | -24.7% |
| 2007 | $36.9B | #56(↓15) | -7.6% |
| 2006 | $39.9B | #41(↓10) | -3.0% |
| 2005 | $41.2B | #31(↑3) | +28.5% |
| 2004 | $32.0B | #34 | +1.5% |
| 2003 | $31.6B | #34(↓6) | +4.1% |
| 2002 | $30.3B | #28(↓6) | -29.8% |
| 2001 | $43.2B | #22(↑18) | +18.8% |
| 2000 | $36.3B | #40 |
その他のヘルスケア企業
よくある質問
What is Sanofi's market cap?
Sanofi (SAN.PA) has a market capitalization of $100.5B, making it the #164 largest company in the world by market cap.
What was Sanofi's highest market cap?
Sanofi's all-time high market cap was $109.9B, reached in 2024-12-31. Its highest rank was #123 in 2024.
What sector is Sanofi in?
Sanofi is in the Healthcare sector, specifically the Drug Manufacturers - General industry. It is based in France.
How has Sanofi's market cap changed over time?
Sanofi has been tracked since 2026. Its market cap has grown by 0% from $100.5B in 2026 to $100.5B today.